General Information of Drug (ID: DMIUW25)

Drug Name
Granisetron Drug Info
Synonyms
BRL-43694; Kytril (TN); Granisetron (USAN/INN); 1-methyl-N-[(1S,5R)-9-methyl-9-azabicyclo[3.3.1]nonan-3-yl]indazole-3-carboxamide; 1-methyl-N-[(3-endo)-9-methyl-9-azabicyclo[3.3.1]non-3-yl]-1H-indazole-3-carboxamide
Therapeutic ClassAntiemetics
Cross-matching ID
PubChem CID
5284566
ChEBI ID
CHEMBL5537
CAS Number
CAS 109889-09-0
TTD Drug ID
D0J5KF
VARIDT Drug ID
DR00439
INTEDE Drug ID
DR0788
ACDINA Drug ID
D00614

Consensus Signature of Drug Pharmacogenomic Perturbation (DPP)

Term Name NES FDR q-val Tag % Leading Edge Genes
Mineral absorption 2.28 0.00e+0 48/60 (80%) MT1E;MT1F;MT1G;...
Proteasome 2.17 0.00e+0 44/46 (95.65%) PSMA6;PSMA3;PSMA5;...
Parkinson disease 1.94 2.75e-3 176/249 (70.68%) UCHL1;PSMA6;NDUFB5;...
Oxidative phosphorylation 1.89 6.18e-3 93/133 (69.92%) NDUFB5;COX5B;NDUFA8;...
Porphyrin and chlorophyll metabolism 1.78 2.47e-2 23/43 (53.49%) UGT2B28;HMBS;FXN;...
Purine metabolism 1.78 2.20e-2 102/129 (79.07%) NUDT9;ADA;GUCY1B1;...
Drug metabolism 1.72 3.88e-2 78/151 (51.66%) GSTO1;ADH5;NAT1;...
Notch signaling pathway -1.67 4.70e-2 49/59 (83.05%) DTX3;TLE1;PTCRA;...
ECM-receptor interaction -1.92 3.53e-2 80/88 (90.91%) ITGA2;THBS4;ITGA7;...
×

Pharmacogenomic Perturbation Across Diseases and Tissues

Breast
Breast adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
MCF7 CVCL_0031 Homo sapiens 0.01uM - 10uM 6H, 24H
Cervix
Cervical adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HeLa CVCL_0030 Homo sapiens 0.01uM - 10uM 3H, 24H
Colon
Colorectal adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HT-29 CVCL_0320 Homo sapiens 0.01uM - 10uM 6H, 24H
Kidney
Normal (Immortalized)
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HA1E CVCL_0284 Homo sapiens 0.01uM - 10uM 6H, 24H
Liver
Hepatoblastoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
Hep G2 CVCL_0027 Homo sapiens 10uM 6H
Hepatocellular carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HuH-7 CVCL_0336 Homo sapiens 10uM 72H
Lung
Lung adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A549 CVCL_0023 Homo sapiens 0.01uM - 10uM 6H, 24H
Non-small cell lung carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HCC515 CVCL_5134 Homo sapiens 10uM 6H
Pancreas
Pancreatic carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
YAPC CVCL_1791 Homo sapiens 0.01uM - 10uM 24H
Prostate
Prostate carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
PC-3 CVCL_0035 Homo sapiens 0.01uM - 10uM 6H, 24H
VCaP CVCL_2235 Homo sapiens 10uM 6H, 24H
Skin
Melanoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A-375 CVCL_0132 Homo sapiens 0.01uM - 10uM 6H, 24H